A report published by Confindustria Study Center showed that, at the end of the first half of this year, Italy’s gross domestic product (GDP) will have fallen by 10% compared to the last quarter of 2019. That represents a loss of around €42 billion in wealth compared to €430 billion in the fourth quarter of 2019.
By the end of 2020, consumption by Italian households will have fallen by 6.8%, business investment by 10.6%, exports by 5.1% and employment by 2.5%, with a 6% drop in GDP.
Discover the latest economic news with the Born2Invest mobile app. Read the most important happenings in the financial world and how countries’ economies are affected by the coronavirus pandemic.
Confindustria’s forecasts are based on the hypothesis that the acute phase of the crisis will end soon
Economists wrote in the introduction of the report that “an unpredictable shock hit the Italian economy in February 2020, when the COVID-19 virus began to spread in the country. This is a joint shock of supply and demand: the progressive, temporary but prolonged blockade of many economic activities on the national territory, necessary to stem the epidemic, was associated with a collapse in demand for goods and services, both from inside and outside Italy. The economic prospects, in this phase of health emergency, are therefore seriously compromised. Moreover, it is not clear when they can be re-established, not even on the supply side”.
Confindustria’s forecasts are based on the assumption that the acute phase of the health emergency will end in the middle of the second quarter of the year. Also, it takes into account that the following percentages of companies will be active in the manufacturing sector in the coming months: April, 40% at the beginning and 60% at the end of the month; May, 70% at the beginning and 90% at the end of the month; June, 90% at the beginning and 100% at the end of the month.
The sharp drop in the country’s GDP is now a reality
The economists continued: “Of the realism, or of the excessive optimism of these hypotheses, only the next few months will say. If the health situation does not evolve positively, in a direction compatible with this supply scenario, the economic forecasts presented should be revised downwards. In 2020, however, a sharp drop in GDP is now inevitable: we forecast it at -6.0%, under the assumption that the acute phase of the health emergency will end in May. This is a fall greater than that of 2009, and completely unexpected at the beginning of the year. Each additional week of regulatory blockage of production activities, according to current parameters, could cost an additional percentage of GDP of the order of at least 0.75%”.
Therefore, “today, it is urgent to avoid that the block of supply and the collapse of demand provoke a dramatic crisis of liquidity in the companies: in the face of the non-deferrable expenses (including those for salary, fiscal and contributory obligations) and the debt burden, the lack of revenue produced by the compression of turnover could jeopardize the very survival of entire production chains. We must prevent the liquidity crisis from becoming a solvency problem, even for companies that had solid balance sheets and prospects before the epidemic.”
The level of liquidity in businesses was moderate at the beginning of the year
Already in the last two years, companies in Italy had suffered a gradual erosion of the liquidity available on their balance sheets, compared to the peak at the end of 2017. This reflected the deterioration in economic growth during that period, accompanied by a gradual reduction in bank credit volumes since 2019. At the beginning of 2020, however, the level of available liquidity in businesses compared to operational needs remained moderate, well above the lows reached in 2013. The impact of the Covid-19 is, therefore, grafted onto an already tense, although not critical, situation on the liquidity front.
Under these conditions, even companies with generally solid balance sheets can have great difficulties in terms of cash flow in the immediate future. If the reduction in revenues exceeds the reduction in costs at the end of the year, the company will make a loss, which could be absorbed by capital and reserves, especially if the scenario improves in the medium term. However, if the problems that drain the cash flow persist for too many weeks (not years), many companies can fall rather quickly into illiquid situations, which risk causing their operations to freeze.
Italy might soon fall into recession
In this emergency phase, banks can play a crucial role if they are able to keep the supply of funding (even short-term) to businesses alive, to restore liquidity and save their current operations. What must be absolutely avoided is the addition of the drying up of internal liquidity within companies with the reduction of loans from banks.
Unfortunately, this has already happened in 2008-2009 and 2012-2013. In both cases, this has been associated with Italy falling into recession. If strong action is not taken on the liquidity emergency, there is a risk that a liquidity problem will turn into a sustainability issue, very quickly, with a significant part of the current stock of credit, also related to solid companies, which turns into non-performing loans for banks, i.e. impaired loans.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Be Beez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
API fintech TrueLayer cashes in on new $70m round lead by Addition
The injection of new capital will be used to accelerate the global expansion and development of premium open banking services,...
Canopy Growth bought out its competition to consolidate leadership
Canopy Growth announced the acquisition of one of its main rivals, Supreme Cannabis, in a transaction valued at $345.6 million...
Aortyx closes €1.6 million financing round to initiate clinical trials
Aortyx, a Barcelona-based startup specialized in devices to treat vascular problems.closes $1.9 million (€1.6 million) financing round. The company, which...
Third successful million-dollar campaign in three months for Walliance
The real estate equity crowdfunding campaign for "Treviso G Park" project raises $2.4 million (€2 million) bringing Walliance's Q1 2021...
US crypto exchange Coinbase had a record quarter before IPO
The US crypto exchange Coinbase has presented brilliant financial figures for the 1st quarter of 2021. This further fuels expectations...
Business7 days ago
Why Elon Musk Should Consider Precious Metals-Backed Currency
Cannabis7 days ago
Senators in Mexico seek agreement on cannabis regulation changes
Featured7 days ago
A close look at the huge margin debt and the Archego Capital collapse
Biotech7 days ago
Boehringer Ingelheim increases revenues by 3% in 2020 to €19.57 billion